FRONTEO,Inc. (2158)

Market cap
¥23.5B
P/E ratio
156.3x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 202611+38.04%
Mar 31, 20257.9-123.28%
Mar 31, 2024-34.1+110.17%
Mar 31, 2023-16.2-247.41%
Mar 31, 202211+236.70%
Mar 31, 20213.3-142.80%
Mar 31, 2020-7.6-1797.78%
Mar 31, 20190.5-108.46%
Mar 31, 2018-5.3-17.90%
Mar 31, 2017-6.5+248.39%
Mar 31, 2016-1.9
AI Chat